Immunome (IMNM) Earnings Analysis
Immunome (IMNM) has no confirmed upcoming earnings date. Last quarter (2026-03-03) it missed with EPS -0.75 USD vs -0.59017 USD est (-27.1%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -9.57.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IMNM next report earnings?
No confirmed upcoming earnings date is currently scheduled for IMNM. This page updates as the calendar is published.
IMNM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-03 | -0.75 USD | -0.59017 USD | -27.1% | Miss |
| 2025-11-06 | -0.65 USD | -0.57 USD | -14% | Miss |
| 2025-05-12 | -0.52 USD | -0.66 USD | +21.2% | Beat |
| 2025-03-19 | -0.84 USD | -0.68 USD | -23.5% | Miss |
| 2024-08-12 | -0.49 USD | -0.38 USD | -28.9% | Miss |
Beat rate: 1/5 (20%) over reported quarters with consensus data.
IMNM valuation and analyst view
| Trailing P/E | -9.57 |
|---|---|
| Trailing EPS | -1.98514 USD |
| Price / book | 4.40 |
| Dividend yield | 0.00% |
| Market cap | 2.16B |
| Analyst consensus | Buy (13 buy / 0 hold / 0 sell) |
| Avg price target | 35.33 USD |
Related research pages
Frequently asked questions
When is Immunome (IMNM)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for IMNM. This page updates as the calendar is published.
Did IMNM beat earnings last quarter?
In its 2026-03-03 report, IMNM posted EPS of -0.75 USD versus a -0.59017 USD estimate — a miss of 27.1%.
What is IMNM's earnings track record?
Over the last 5 reported quarters with consensus data, IMNM beat estimates 1 times (20%).
What is IMNM's current P/E ratio and EPS?
IMNM trades at a trailing P/E of -9.57 on trailing EPS of -1.9851447852050592 USD.
What do analysts rate IMNM?
Analyst consensus is "Buy" across 13 ratings (0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 35.33 USD.